Applied Genetic Technologies Corporation
TRIPLE FUNCTION ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF C9ORF72 ASSOCIATED DISEASES
Last updated:
Abstract:
The present disclosure provides isolated promoters, transgene expression cassettes, vectors, kits, and methods for treatment of C9ORF72 associated diseases, including ALS and FTD.
Status:
Application
Type:
Utility
Filling date:
22 Oct 2020
Issue date:
20 May 2021